Compare Immunovant Inc. Common Stock (IMVT) vs Cheniere Energy (LNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Cheniere Energy — how do they compare? Immunovant Inc. Common Stock trades at $30.22 (market cap $6.25B), while Cheniere Energy trades at $278.78 (market cap $57.39B). The key difference: Cheniere Energy is far larger — about 9.2× Immunovant Inc. Common Stock's market cap, and Cheniere Energy pays a 0.8% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Cheniere Energy for 10 Days on average.
| IMVT | LNG | |
|---|---|---|
Market Cap | $6.25B | $57.39B |
Volume | 1,755,411 | 1,215,835 |
Sector | Health | Energy |
52-Week High | $44.96 | $296.91 |
52-Week Low | $17.03 | $188.83 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $5.35B | $82.85B |
Dividend Yield | — | 0.8% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Cheniere Energy
Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →
